This opportunity funds research to enhance mechanistic understanding of neuropsychiatric symptoms in Alzheimer's disease and related dementias. It supports studies exploring biobehavioral and neurobiological pathways and aims to identify novel therapeutic targets for treatment and prevention of these symptoms.
Eligible applicants include a wide range of U.S. organizations such as government entities, nonprofits, institutions of higher education, for-profit organizations, small businesses, and tribal governments. Specific eligibility details are provided in the announcement.
